Beth Levant

Title: The Innovations of Beth Levant

Introduction

Beth Levant is an accomplished inventor based in Kansas City, MO. She has made significant contributions to the field of pharmacology, particularly in the development of ligands for the dopamine 3 (D3) receptor. With a total of 2 patents, her work has the potential to impact the treatment of various diseases.

Latest Patents

Beth Levant's latest patents focus on potent and selective ligands for the dopamine 3 (D) receptor. The first patent discloses ligands with a structural formula where R is either Calkyl or Ccycloalkyl, and may be substituted with one or two halogens or OCalkyl. The second patent also addresses ligands for the D3 receptor, detailing a structural formula where X is C=O or SO, and R can be Calkyl, aryl, heteroaryl, or other specified structures. Both patents include methods for using these ligands in the treatment of diseases where modulation of the D3 receptor is beneficial.

Career Highlights

Beth has worked at prestigious institutions such as the University of Michigan and the University of Kansas Medical Center Research Institute. Her research has contributed to advancements in understanding the D3 receptor and its implications in various medical conditions.

Collaborations

Beth has collaborated with notable colleagues, including Shaomeng Wang and Jianyong Chen, enhancing her research through shared expertise and innovative ideas.

Conclusion

Beth Levant's work exemplifies the intersection of innovation and medical research, showcasing her dedication to advancing pharmacological treatments. Her contributions to the field are significant and continue to pave the way for future discoveries.